Carevive’s Longitudinal Data

At Carevive, our commitment to enhancing cancer care through data-driven insights is at the core of our mission. Our real-time, longitudinal data set offers comprehensive and up-to-date information on patient experiences throughout their cancer journey.

With over 1,700 patients represented across 26 cancer types, our registry provides a wealth of information from more than 19,000 completed surveys conducted over two years. This rich dataset encompasses over 600,000 unique data points, providing valuable information for analysis and personalized care planning.

One of the key strengths of our approach is seamless integration with the care process. Our surveys are presented to patients by their care teams, ensuring an outstanding survey response rate of 82% or higher for some indications. This compliance underscores the importance of patient engagement in the treatment process.

Carevive’s real-time data empowers care teams with valuable insights, enabling them to make informed decisions, proactively address patient concerns, and optimize treatment plans. Our commitment to advancing cancer care through data excellence sets the stage for continued innovation and improved patient outcomes.

Recent Episodes

As we get into the Halloween spirit, many are looking for that perfect finishing touch for their costumes, and cosmetic contact lenses are a popular choice. However, Dr. Emily Eisenhower offers a timely warning: while they may look great, these lenses can pose serious vision risks. She cautions that improper lenses can lead to…

Sterile Processing Departments (SPDs) are the unsung backbone of surgical care — ensuring every instrument, tray, and tool is safe, sterile, and ready when needed. Yet, despite their vital role, SPD workflows often rely on manual processes and underrecognized best practices. As healthcare systems push for greater efficiency and staff well-being, SPD managers are turning…

Cardiovascular care is entering one of its most transformative periods in decades. Advances in AI imaging and minimally invasive procedures are transforming the diagnosis and treatment of heart disease. According to the World Health Organization, an estimated 19.8 million people died from cardiovascular diseases in 2022, representing approximately 32% of all global deaths. This…